Results 161 to 170 of about 10,093 (182)

Omalizumab

Drugs of the Future, 2002
null Cullell-Young, M., null Bayes, M., null Leeson, P.A.   +2 more
openaire   +1 more source

Omalizumab

Reactions Weekly, 2022
openaire   +2 more sources

The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change

Allergy: European Journal of Allergy and Clinical Immunology, 2018
Tomasz Hawro, Marcus Maurer, Ragip Ertaş   +2 more
exaly  

Safety and tolerability of omalizumab

Clinical and Experimental Allergy, 2009
Thomas Casalé
exaly  

Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort

Journal of Allergy and Clinical Immunology, 2020
Lucie Blais, Michael Cabana, John M Thorp   +2 more
exaly  

Omalizumab

Reactions Weekly, 2009
openaire   +2 more sources

Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma

American Journal of Respiratory and Critical Care Medicine, 2017
Stephen Teach, Jeremy Wildfire, James Gern   +2 more
exaly  

Omalizumab and the risk of malignancy: Results from a pooled analysis

Journal of Allergy and Clinical Immunology, 2012
Janice Canvin, William Busse, Mark D Eisner   +2 more
exaly  

Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy

Allergy and Asthma Proceedings, 2007
Hamilton Robert G
exaly  

Effectiveness of omalizumab (Xolair®) in the first patients treated in real-life practice in France

Respiratory Medicine, 2008
Frédéric De Blay, Mathieu Molimard, Vincent Le Gros   +2 more
exaly